KLAS Research did a Spotlight report on LeanTaaS’ IQ for Infusion Centers product, which scored a 92.9 out of 100. Customers are extremely satisfied with the product’s performance.

Reducing the infusion time for nivolumab and pembrolizumab to 10 minutes is feasible and safe, according to researchers.

Local Infusion is expanding its network of outpatient infusion centers, aiming to redefine the treatment experience for ...